Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Steven B. Sands | M | 65 |
OptMed, Inc.
 OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 13 years |
| Martin S. Sands | M | 63 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 13 years |
| Kenneth Burhop | M | 71 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 2 years |
| Ervin Braun | M | 69 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 12 years |
| James Chao | M | 62 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 2 years |
| Curtis L. Cetrulo | M | 54 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 2 years |
| de la Fuente Veronica | M | - |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
| Rui Ping Dong | M | 62 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 4 years |
| Ciaran McArdle | M | - |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
| Burrows H.F. | M | - |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Madelyn Antonic | M | - |
The Leonard N Stern School of Business
| 4 years |
| Richard Berenson Stone | M | 81 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
| David Alan Liebowitz | M | - |
The Leonard N Stern School of Business
| 6 years |
| Michael S. Jellinek | M | - |
Yeshiva University
| 3 years |
| John P. Simpson | M | - |
The Leonard N Stern School of Business
| 2 years |
| Anthony M. Collura | M | - |
The Leonard N Stern School of Business
| 4 years |
| Gerald Bruce Levin | M | - |
The Leonard N Stern School of Business
| 3 years |
| Mary Lucy Colson Flood | F | - |
The Leonard N Stern School of Business
| 2 years |
| Kenneth J. Blank | M | - |
Yeshiva University
| 3 years |
| Gerry Malone | M | - |
The Leonard N Stern School of Business
| 2 years |
| Barry Ginsberg | M | - |
Yeshiva University
| 4 years |
| Scott Cauchois Sartorius | M | - |
The Leonard N Stern School of Business
| 2 years |
| Michael Hopkins | M | - |
Yeshiva University
| 3 years |
| Richard A. Serko | M | - |
Yeshiva University
| 3 years |
| Jeff Hall | M | - |
The Leonard N Stern School of Business
| 4 years |
| Jeffrey E. Ungar | M | 65 |
Yeshiva University
| 4 years |
| Richard Perry | M | 69 |
The Leonard N Stern School of Business
| 2 years |
| Sheldon Myles Goldman | M | - |
Yeshiva University
| 4 years |
| Yuan Huai Tso | M | - |
Yeshiva University
| 3 years |
| Gerald Adler | M | 66 |
Yeshiva University
| 4 years |
| John Ng | M | - |
The Leonard N Stern School of Business
| 4 years |
| Alfred Mansour | M | - |
Yeshiva University
| 4 years |
| Avi Katz | M | 65 |
Yeshiva University
| 4 years |
| Shelley Fredrick Greenhaus | M | 71 |
The Leonard N Stern School of Business
| 2 years |
| Adele Susan Weisman | F | 78 |
The Leonard N Stern School of Business
| 2 years |
| Douglas Greeff | M | 68 |
The Leonard N Stern School of Business
| 1 years |
| Leigh Wood | M | - |
The Leonard N Stern School of Business
| 5 years |
| Lottie H. Shackelford | F | 82 |
Yeshiva University
| 4 years |
| Peter J. Rogers | M | 68 |
The Leonard N Stern School of Business
| 2 years |
| Samuel Schussler | M | 71 |
The Leonard N Stern School of Business
| 2 years |
| Robert H. Lamb | M | 82 |
The Leonard N Stern School of Business
| 40 years |
| Henry Schachar | M | - |
Yeshiva University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 42 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alain Klapholz
- Personal Network
